Amundi Discloses Strategy Stake Up 44% at $291 Million

Amundi disclosed nearly 1.9 million Strategy shares worth $291 million on Sept. 30, up 44% from June 30, in a combined 13F filed Nov. 6. The Nov. 6 filing records a Strategy line for Europe’s biggest asset manager, but it does not establish that Amundi bought every share with proprietary capital.

What does Amundi’s 13F actually show?

A 13F is a snapshot, not a trading diary. Amundi’s combination report folds in 17 other managers across its group, so the Strategy line can include client, fund and discretionary positions rather than a single proprietary bet. The firm may also have changed the holding after Sept. 30.

Amundi’s June 30 13F valued its then-smaller Strategy position at an implied $86.93 per share, against MSTR’s $153.09 Sept. 30 close. The stock roughly doubled during the third quarter, so the position’s dollar value rose faster than its share count.

Since then, MSTR has tracked bitcoin’s slide into the mid-$70,000s, eroding much of that mark-to-market gain for anyone who retained the Sept. 30 position. At Monday’s close, the disclosed stake stood about $52 million below its Sept. 30 mark, even though the filing’s share count had stayed fixed.

How does Strategy finance its bitcoin purchases?

Strategy bought another 1,036 bitcoin last week for $81.9 million at an average of $79,012, according to a Monday 8-K filing and company release. The purchase lifted its treasury to 850,364 BTC acquired for $64.16 billion, at an average cost of $75,456 per coin. Strategy had added 811 bitcoin the prior week.

That average cost now exceeds the spot bitcoin price, leaving the stack underwater on paper despite the latest purchase. Strategy’s public ledger still ranks the company as the largest corporate bitcoin holder. Its 850,364 BTC equal roughly 4% of bitcoin’s 21 million supply cap.

Strategy funds most of its bitcoin purchases by selling new MSTR common stock through an at-the-market program. A weaker share price increases the dilution required for each coin purchased, sustaining the feedback loop that has defined the stock’s moves this year. That financing structure makes equity-market access central to each additional bitcoin acquisition.

What did Barclays add in Q3?

Barclays’ own 13F, filed Nov. 6, showed 3,942,900 shares of BlackRock’s iShares Bitcoin Trust, or IBIT, worth $186.7 million at Sept. 30. The position was up 48% from 2,658,147 shares three months earlier, according to SEC records.

Like Amundi’s filing, Barclays’ 13F gathers client, managed and trading-book positions, so it does not prove that the bank invested its own capital in bitcoin. Together, the two filings show traditional European managers adding bitcoin-proxy exposure during the third quarter as the spot market cooled into autumn.

After quarter-end, bitcoin slipped into the mid-$70,000s and MSTR followed it down. Amundi’s disclosed position therefore lost value after Sept. 30 even though its reported share count remained unchanged.

What will the next filing reveal?

Whether Amundi kept buying, trimmed the position or simply held through October’s slide will not appear until the next 13F. For now, the Nov. 6 filing establishes the recorded quarter-end position: nearly 1.9 million Strategy shares, a 44% increase, worth $291 million.

The next quarterly 13F will provide the first filing-based check on those changes; future MSTR at-the-market issuance will show how much equity dilution accompanies additional bitcoin purchases.